Fermelanta, Inc.
PrivateLast Round
Series A
Aug 28, 2025
Total Funding Raised
$15.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Fermelanta, Inc. operates in Healthcare & Life Sciences and is based in Nonoichi. Its latest recorded funding round was a Series A round in August 2025.
Fermelanta, Inc. is a biotechnology company that develops plant secondary metabolites using a microbial fermentation process for industrial raw materials and ingredients including medicines, cosmetics, or supplements.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fermelanta, Inc. Comparables
Compare Fermelanta, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Conagen | 83% | |
| Antheia | 76% | |
| Manus Bio | 76% |
For institutional investors. Book with your work email.
Fermelanta, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 28, 2025 | ||||
| Seed | Jun 13, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Fermelanta, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angel Bridge | Series A, Seed |
| Keio Innovation Initiative | Series A |
| Universal Materials Incubator | Series A |
| Norinchukin Capital Co., Ltd. | Series A |
| Plug and Play Japan | Seed |
| Beyond Next Ventures | Seed, Series A |
| Mitsubishi UFJ Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 49% MoM.
- May 12, 2026
Monthly visitors grew 164% MoM, reaching 3.7K.
For institutional investors. Book with your work email.
Fermelanta, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fermelanta, Inc.'s valuation, stock price, and market status.
Is Fermelanta, Inc. a public or private company?
Fermelanta, Inc. is a private company.
What is the current stock price of Fermelanta, Inc.?
Fermelanta, Inc. is a private company, so its shares have no public market price. Caplight tracks Fermelanta, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fermelanta, Inc. worth (valuation)?
Valuation information for Fermelanta, Inc. is not publicly available.
Can I buy Fermelanta, Inc. stock?
Fermelanta, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fermelanta, Inc.'s last funding round?
Fermelanta, Inc.'s most recent funding round was Series A on August 28, 2025.
Who are the main investors in Fermelanta, Inc.?
Key investors in Fermelanta, Inc. include Universal Materials Incubator, Beyond Next Ventures.
Will Fermelanta, Inc. IPO soon?
No public IPO plans have been announced for Fermelanta, Inc..
How can I track Fermelanta, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Fermelanta, Inc.'s shares on secondary markets.